Dose response of umeclidinium administered once or twice daily in patients with COPD: a randomised cross-over study

BACKGROUND: Umeclidinium bromide (UMEC) is an inhaled long-acting muscarinic antagonist in development for chronic obstructive pulmonary disease (COPD). METHODS: This was a multicentre, randomised, double-blind, placebo-controlled, three-way cross-over, incomplete block study to evaluate UMEC 15.6,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Church, Alison, Beerahee, Misba, Brooks, Jean, Mehta, Rashmi, Shah, Palvi
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4029330/
https://ncbi.nlm.nih.gov/pubmed/24393134
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2466-14-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados